NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/05/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization242.69 mln
Float72.95 mln
Earnings Date05/07/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.56
Highly reliable
Relative Strength
92
/ 100
Top performer
Debt / Equity
1.45
Elevated leverage
ROE
-84.16
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Codexis is a biotechnology company based in Redwood City, California, that uses its proprietary enzyme engineering technology to help manufacturers produce therapeutic drugs more efficiently. Its platform is used to design and improve enzymes that support the large-scale production of RNA-based medicines, among other applications. The company operates across North America, Europe, the Middle East, Asia, and beyond, and works with partners such as Pfizer and Aldevron under licensing agreements.
